Long-term follow-up of oral tolerance induction with HLA-peptide B27PD in patients with uveitis

Annals of the New York Academy of Sciences

Volumn 1029, Issue , 2004, Pages 408-412

  Thurau, Stephan R ^a   Fricke, Harald ^b   Burchardi, Christian ^b   Diedrichs Möhring, Maria ^a   Wildner, Gerhild ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Autoimmune disease; Mimicry; Patient trial; Peptide; Tolerance induction; Uveitis

Indexed keywords

AUTOANTIGEN; CORTICOSTEROID; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; HLA B27PD ANTIGEN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CROSS REACTION; DISEASE COURSE; FOLLOW UP; HUMAN; IMMUNOLOGICAL TOLERANCE; MOLECULAR MIMICRY; ORAL TOLERANCE; T LYMPHOCYTE; UVEITIS; VISUAL ACUITY; VITRECTOMY;

EID: 14544292381     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1309.048     Document Type: Conference Paper

References (8)

1. DE-SMET, M.D. et al. 2001. Human S-antigen determinant recognition in uveitis. Invest. Ophthalmol. Vis. Sci. 42: 3233-3238.
2. WILDNER, G. & S.R. THURAU. 1994. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur. J. Immunol. 24: 2579-2585.
3. WEINER, H.L. 2000. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J. Clin. Invest. 106: 935-937.
4. NUSSENBLATT, R.B. et al. 1997. Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am. J. Ophthalmol. 123: 583-592.
5. THURAU, S.R. & G. WILDNER. 2002. Oral tolerance for treating uveitis - new hope for an old immunological mechanism. Prog. Ret. Eye. Res. 21: 577-589.
6. THURAU, S.R. & G. WILDNER. 2003. An HLA-peptide mimics organ-specific antigen in autoimmune uveitis: its role in pathogenesis and therapeutic induction of oral tolerance. Autoimm. Rev. 2: 171-176.
7. THURAU, S.R. et al. 1997. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen-first results. Immunol. Lett. 57: 193-201.
8. THURAU, S.R. et al. 1999. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis. Immunol. Lett. 68: 205-512.